Won-Sik Lee

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Je‐Hwan Lee, Young‐Don Joo, Hawk Kim et al. · Blood · 2011 · 147 citations · Full text

Medicine, Hematology, Oncology +14

Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study

Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae et al. · Cancer Chemotherapy and Pharmacology · 2007 · 112 citations

Medicine, Oncology, Chemotherapy +13

Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

Je‐Hwan Lee, Hawk Kim, Young‐Don Joo et al. · Journal of Clinical Oncology · 2017 · 85 citations

Medicine, Oncology, Pharmacotherapy +15

Inhibition of acute lethal pulmonary inflammation by the IDO–AhR pathway

Soung-Min Lee, Ha Young Park, Young-Sill Suh et al. · Proceedings of the National Academy of Sciences · 2017 · 81 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Tryptophan metabolite 3-hydroxyanthranilic acid selectively induces activated T cell death via intracellular GSH depletion

Sun‐Mi Lee, Young-Suk Lee, Jae-Hyeog Choi et al. · Immunology Letters · 2010 · 80 citations

Life Sciences, Biochemistry, Immunology +14